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ARTICLE
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National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia
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ABSTRACT
BACKGROUND. Beginning in 2002 the Advisory Committee on Immunization Practices

encouraged, when feasible, annual influenza vaccination of all children aged 6 to
23 months and household contacts and out-of-home caregivers of children ⬍2
years of age.
OBJECTIVE. We sought to report influenza vaccination coverage for the 2002–2003

and 2003–2004 influenza seasons among children aged 6 to 23 months according
to demographic and immunization-provider characteristics.
METHODS. Data from the 2003 and 2004 National Immunization Survey were ana-

lyzed. Two measures of childhood influenza vaccination are reported: receipt of
ⱖ1 influenza vaccination and full vaccination (ie, receipt of the appropriate
number of doses on the basis of previous vaccination history). 2 tests and
logistic-regression analyses to test for associations between influenza vaccination
status and demographic characteristics were performed.
RESULTS. In the 2002–2003 and 2003–2004 influenza seasons only 7.4% and 17.5%,

respectively, of children aged 6 to 23 months received ⱖ1 influenza vaccination,
whereas only 4.4% and 8.4%, respectively, were fully vaccinated. In both seasons,
adjusted influenza vaccination coverage was significantly lower among children
living below the poverty level; non-Hispanic black children; older children; children with less-educated mothers; children vaccinated only at public clinics; and
children not residing in a metropolitan statistical area.
CONCLUSIONS. During the first 2 years of the Advisory Committee on Immunization

Practices’ encouragement for children aged 6 to 23 months to receive influenza
vaccination, coverage was low, with significant demographic differences in receipt
of vaccination. Beginning with the 2004 –2005 influenza season, they replaced the
encouragement with a recommendation that children aged 6 to 23 months receive
annual influenza vaccination. Substantial work remains to fully and equitably
implement this new recommendation and ensure vaccination with 2 doses for
previously unvaccinated children.
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D

URING 1990 –1999, INFLUENZA caused an average of
⬃36 000 underlying circulatory and respiratory
deaths per year in the United States; ⬎90% of these
deaths occurred in persons aged ⱖ65, and one quarter of
1% (0.25%) occurred in children ⬍5 years of age.1 Although children do not represent a large percentage of
the deaths from influenza, studies have shown that children carry a large burden of hospitalizations resulting
from influenza.2–5 During 1979 –2001, influenza was associated with an average of ⬎200 000 primary respiratory and circulatory hospitalizations per year, with
⬃20 000 (10%) of these hospitalizations for children ⬍5
years of age.4 The rates of influenza-related hospitalizations among children aged ⬍5 years ranged from ⬃100
in 100 000 children for those without high-risk conditions to 500 in 100 000 children for those with high-risk
medical conditions; the highest rates were among children aged ⬍2 years, which were comparable to rates of
persons ⱖ65 years.5
Because children ⬍2 years of age have been found to
be at increased risk of influenza-related hospitalization,
beginning in 2002 the Advisory Committee on Immunization Practices (ACIP) encouraged, when feasible,
that all children 6 to 23 months of age, and the household contacts and out-of-home caregivers of children ⬍2
years of age, receive influenza vaccination each influenza season.2,3,6 Children ⬍6 months are not eligible for
influenza vaccination. Beginning with the 2004 –2005
influenza season, the ACIP strengthened the encouragement to a recommendation.5
Here we examine influenza vaccination coverage for
the 2002–2003 and 2003–2004 influenza seasons among
children aged 6 to 23 months according to various demographic and immunization-provider characteristics.

METHODS
Data from the 2003 and 2004 National Immunization
Survey (NIS) were analyzed. The NIS is an ongoing
random-digit-dial telephone household survey followed
by a mail survey to children’s vaccination providers that
provides estimates of vaccination coverage among noninstitutionalized children aged 19 to 35 months at the
time of the household interview. The survey is conducted in each of the 50 states and 28 selected urban
areas.7,8 In 2003, collection of each child’s entire influenza vaccination history was added to the instrument by
which providers report children’s vaccination histories
to the NIS. Children included in the 2003 NIS were born
from January 2000 through July 2002, and children
included in the 2004 NIS were born from January 2001
through July 2003.
Two measures of childhood influenza vaccination
coverage, based on provider-reported dates of vaccination, are reported for each influenza season. Using the
2003 NIS to obtain estimates for the 2002–2003 influenza season, the 2 measures were defined as (1) receipt
1168
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of ⱖ1 influenza vaccination during September 1, 2002,
to December 31, 2002, and (2) full vaccination, based on
ACIP recommendations that children ⬍9 years of age
and previously unvaccinated against influenza should
receive 2 doses, whereas all previously vaccinated children ⬍9 years of age require only 1 dose.5 For this
second measure, children were considered fully vaccinated if they had (1) received no doses of influenza
vaccine before September 1, 2002, but then received 2
doses between September 1, 2002, and January 31, 2003
(or interview date if interviewed in January), or (2)
received at least 1 dose of influenza vaccine before September 1, 2002, and then received at least 1 dose between September 1, 2002, and December 31, 2002. Because children ⬍6 months of age are not eligible for
vaccination and the encouragement (and now the recommendation) is for vaccination of children 6 to 23
months, we restricted analyses for both measures to
include only those children who were 6 to 23 months of
age during the entire span of September 1, 2002, to
December 31, 2002. A similar methodology and time
frames were used to analyze the 2004 NIS.
Respondent-reported demographic characteristics included child’s race/ethnicity (Hispanic, white non-Hispanic, black non-Hispanic, Asian non-Hispanic, American Indian/Alaska Native, or all other non-Hispanic),
first-born status, and gender; maternal age (ⱕ19, 20 –29,
or ⱖ30 years), education level (⬍12 years, 12 years, ⬎12
years noncollege graduate, or college graduate), and
marital status (widowed/divorced/separated, never married, married); poverty status (above the poverty threshold and more than $75 000/year, above the poverty
threshold and $75 000/year or less, below the poverty
threshold, or unknown), number of children ⬍18 years
old in the household (1, 2–3, or ⱖ4), and mobility
(moved from a different state since birth, did not move,
or unknown). Poverty status was defined using US Census Bureau poverty thresholds. American Indian, Alaska
Native, and other non-Hispanic respondents were aggregated to satisfy minimum standards of statistical stability
of coverage estimates (eg, observations in numerator
⬎30). Provider-reported data included facility type at
which vaccinations were received (all public clinics, all
hospitals, all private practices, or other/mixed/unknown) and up-to-date (UTD) 4:3:1:3:3 (receipt, by age
19 –35 months [child’s date at time of interview for
inclusion in the NIS], of ⱖ4 doses of diphtheria and
tetanus toxoids and pertussis vaccine, ⱖ3 doses of poliovirus vaccine, ⱖ1 dose of any measles-containing vaccine, ⱖ3 doses of Haemophilus influenzae type b vaccine,
and ⱖ3 doses of hepatitis B vaccine) vaccination coverage. Other demographics included census region (Northeast, Midwest, South, West), metropolitan statistical
area (MSA) designation (MSA central city, MSA noncentral city, non-MSA), child’s age at the start of the
influenza season (September 1), and shot-card usage.

2 analyses were performed, to test for associations
between influenza vaccination status and demographic
characteristics, and were followed by posthoc pairwise
comparisons; percentages are reported with 95% confidence interval (CI) half-widths. Two sets of logisticregression analyses were performed to determine variables independently associated with (1) receipt of ⱖ1
influenza vaccination or (2) being fully vaccinated for
influenza. We selected the reference categories so that
the odds ratios (ORs) were ⱖ1. Both models were run
while including and then excluding the variable 4:3:1:
3:3 UTD status. ORs are reported with 95% CIs. Data
were weighted to adjust for households with multiple
telephone lines, for unit nonresponse, for nonassessment of households without telephones, and to adjust to
known population control estimates.7–9 National estimates were obtained by using these weighting adjustments. A 2-sided significance level of .05 was adopted
for all statistical tests. All analyses were conducted by
using SAS 9.1 (SAS Institute, Inc, Cary, NC) and
SUDAAN 9.0.0 (Research Triangle Institute, Research
Triangle Park, NC), a statistical package designed for
analyses of complex survey data.
RESULTS
The Council of American Survey Research Organizations
response rates, a standard approach for measuring response rates for random-digit-dial surveys, for the 2003
and 2004 NIS were 69.8% and 73.1%, respectively;
health care provider vaccination records were then obtained for 68.9% (21 310) and 71.6% (21 998) of the
children, respectively. For the 2002–2003 influenza season we restricted our analyses to 13 831 children (unweighted) who were 6 to 23 months of age during the
entire span of September 1, 2002, to December 31, 2002;
for the 2003–2004 season we restricted our analyses to
13 881 children (unweighted) who were aged 6 to 23
months of age during the entire span of September 1,
2003, to December 31, 2003. The data included in this
study, although a subset of the 2003 NIS and 2004 NIS
data sets, are a nationally representative sample of children. Table 1 displays the demographic characteristics of
children included in this study, which are consistent
with characteristics of the entire NIS sample for each
year.
In the 2002–2003 and 2003–2004 influenza seasons,
only 7.4% (⫾0.7%) and 17.5% (⫾1.1%), respectively,
of the children received at least 1 dose of influenza
vaccine, and 4.4% (⫾0.5) and 8.4% (⫾0.8), respectively, were fully vaccinated (Table 2). In the 2002–2003
season, of the 7.4% who received at least 1 dose, 40%
were not fully vaccinated; in the 2003–2004 season, of
the 17.5% who received at least 1 dose, 52% were not
fully vaccinated.
Table 2 includes influenza vaccination coverage according to demographic characteristics. Hispanic and

non-Hispanic black children had significantly lower influenza vaccination coverage than both non-Hispanic
white and non-Hispanic Asian children. Children in
households with lower income levels had lower influenza vaccination coverage than children in households
that were well above the poverty level. Children of
mothers who had lower education, were unmarried, or
were younger had lower influenza vaccination coverage
than children of mothers who were college educated,
married, and older. Living in a household with ⱖ4 children was associated with lower vaccination coverage
compared with living in a household with fewer children. Children who received all of the vaccines from
public clinics had lower influenza vaccination coverage
than children who received their vaccinations at other
facility types, and children residing in non-MSA areas
had lower influenza vaccination coverage than those
residing in other areas.
Results of the multivariable logistic-regression models
to examine the association between demographic characteristics and (1) receipt of ⱖ1 influenza vaccination
and (2) being fully vaccinated while controlling for all
other demographics in the model are presented in Table
3 for the 2 influenza seasons. Child’s race (white, Asian),
poverty status (higher income), younger age at the start
of the influenza season, and provider facility type (private and hospitals) all remained significantly associated
with receipt of ⱖ1 influenza vaccination while controlling for other demographics for both the 2002–2003 and
2003–2004 influenza seasons. Child’s race (Asian [in the
2002–2003 model] and white [in the 2003–2004
model]), mother’s education (college graduate), MSA
(central city [in the 2002–2003 model] and noncentral
city [in the 2003–2004 model]), and provider facility
type (private) all remained significantly associated with
being fully vaccinated for influenza for both influenza
seasons (Table 3).
The above-described models were recomputed including 4:3:1:3:3 UTD status in addition to the other
demographic variables (data not shown). For the models
examining associations with ⱖ1 influenza vaccination,
the 4:3:1:3:3 UTD variable dominated the models (ie,
had a very large OR); children 4:3:1:3:3 UTD had an OR
of 3.1 (95% CI: 2.2– 4.3) in 2002–2003 and 2.3 (95% CI:
1.8 –2.9) in 2003–2004 of receiving ⱖ1 influenza vaccination compared with children who were not 4:3:1:3:3
UTD. Similar results were found for the model to examine associations with being fully vaccinated for influenza; children 4:3:1:3:3 UTD had an OR of 4.0 (95% CI:
2.5– 6.6) in 2002–2003 and 2.7 (95% CI: 1.9 – 4.0) in
2003–2004 of being fully vaccinated for influenza compared with children who were not 4:3:1:3:3 UTD.
DISCUSSION
Our findings indicate that during the first 2 influenza
seasons that the ACIP encouraged influenza vaccination
PEDIATRICS Volume 118, Number 3, September 2006
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TABLE 1 Distribution of Samples According to Demographic Characteristics
Demographic Characteristic

2002–2003 Inﬂuenza Seasona
Unweighted n

Overall
Child’s race/ethnicity
Hispanic
White, non-Hispanic
Black, non-Hispanic
Asian, non-Hispanic
American Indian/Alaska Native and other, non-Hispanic
First born
No
Yes
Gender
Male
Female
Poverty statusc
Above, more than $75 000/y
Above, $75 000/y or less
Below
Unknown
Child’s age at start of the inﬂuenza season
6–11 mo
12–16 mo
17–20 mo
Mother’s education level
⬍12 y
12 y
⬎12 y, noncollege graduate
College graduate
Mother’s marital status
Widowed/divorced/separated
Never married
Married
Mother’s age
ⱕ19 y
20–29 y
ⱖ30 y
Shot card used
Yes
No
Census region
Northeast
Midwest
South
West
MSA
MSA, central city
MSA, noncentral city
Non-MSA
No. of children ⬍18 y old in household
1
2–3
ⱖ4
Provider facility type
All public
All hospitals
All private
Other, mixed, unknown
Moved from a different stated
Moved
Did not move
4:3:1:3:3
UTD
Not UTD

13 831

Weighted %
(⫾95% CI Half-width)
100.0

2003–2004 Inﬂuenza Seasonb
Unweighted n
13 881

Weighted %
(⫾95% CI Half-width)
100.0

2958
8143
1913
616
201

26.8 (⫾1.2)
53.5 (⫾1.3)
13.9 (⫾1.0)
4.8 (⫾0.7)
1.1 (⫾0.2)

2877
8387
1780
646
191

27.9 (⫾1.4)
52.4 (⫾1.5)
14.0 (⫾1.1)
4.6 (⫾0.6)
1.1 (⫾0.3)

8351
5480

61.5 (⫾1.3)
38.5 (⫾1.3)

8435
5446

63.1 (⫾1.4)
36.9 (⫾1.4)

7054
6777

50.8 (⫾1.4)
49.2 (⫾1.4)

7083
6798

51.0 (⫾1.5)
49.0 (⫾1.5)

2885
6932
2743
1271

15.0 (⫾0.8)
46.7 (⫾1.4)
24.5 (⫾1.3)
13.8 (⫾1.1)

3309
6735
2611
1226

16.3 (⫾0.9)
45.1 (⫾1.5)
26.3 (⫾1.5)
12.3 (⫾1.1)

4041
6124
3666

29.2 (⫾1.3)
44.1 (⫾1.4)
26.7 (⫾1.2)

3816
6335
3730

27.0 (⫾1.4)
46.1 (⫾1.5)
26.9 (⫾1.3)

1953
3574
2636
5668

23.0 (⫾1.3)
30.6 (⫾1.3)
21.4 (⫾1.1)
25.0 (⫾1.0)

1703
3490
2634
6054

22.3 (⫾1.5)
31.0 (⫾1.4)
21.4 (⫾1.2)
25.3 (⫾1.1)

978
2758
10 095

8.4 (⫾0.8)
23.1 (⫾1.2)
68.6 (⫾1.3)

853
2582
10 446

8.4 (⫾0.9)
23.2 (⫾1.3)
68.5 (⫾1.5)

371
5789
7671

3.7 (⫾0.6)
46.8 (⫾1.4)
49.6 (⫾1.4)

334
5618
7929

3.2 (⫾0.6)
47.1 (⫾1.5)
49.7 (⫾1.5)

6544
7287

45.1 (⫾1.3)
54.9 (⫾1.3)

5769
8112

39.5 (⫾1.5)
60.5 (⫾1.5)

2360
3099
5147
3225

17.2 (⫾0.7)
21.3 (⫾0.8)
37.2 (⫾1.0)
24.3 (⫾0.9)

2299
3143
5087
3352

17.1 (⫾0.9)
21.7 (⫾0.9)
36.3 (⫾1.1)
24.8 (⫾1.1)

6084
4896
2851

35.2 (⫾1.2)
46.9 (⫾1.3)
17.9 (⫾0.9)

6124
4887
2870

36.3 (⫾1.4)
45.4 (⫾1.5)
18.3 (⫾1.0)

3841
8334
1656

26.6 (⫾1.2)
59.3 (⫾1.4)
14.2 (⫾1.1)

3884
8323
1674

26.1 (⫾1.3)
60.3 (⫾1.5)
13.5 (⫾1.1)

1967
1259
8569
1966

15.5 (⫾1.0)
8.7 (⫾0.8)
61.3 (⫾1.3)
14.6 (⫾1.0)

1776
1275
8610
2147

15.8 (⫾1.2)
8.2 (⫾0.8)
60.9 (⫾1.5)
15.1 (⫾1.1)

1070
12 722

8.4 (⫾0.8)
91.6 (⫾0.8)

985
12 871

7.5 (⫾0.8)
92.5 (⫾0.8)

11 060
2771

78.5 (⫾1.2)
21.5 (⫾1.2)

11 296
2585

79.8 (⫾1.2)
20.2 (⫾1.2)

a Inﬂuenza vaccination coverage measures for the 2002–2003 inﬂuenza season are based on data from the 2003 NIS and represent a subset of children included in the NIS. Only those who were
between the ages of 6 and 23 months for the entire period of September 1, 2002, to December 31, 2002, are included in the inﬂuenza vaccination coverage measures.
b Inﬂuenza vaccination coverage measures for the 2003–2004 inﬂuenza season are based on data from the 2004 NIS and represent a subset of children included in the NIS. Only those who were
between the ages of 6 and 23 months for the entire period of September 1, 2003, to December 31, 2003 are included in the inﬂuenza vaccination coverage measures.
c Deﬁned using US Census Bureau poverty thresholds.
d Unknown responses were excluded (n ⫽ 39 for 2002–2003 and n ⫽ 25 for 2003–2004).

TABLE 2 Inﬂuenza Vaccination Coverage Levels Among Children Aged 6 to 23 Months According to Demographic Characteristics
Demographic Characteristic

2002–2003 Inﬂuenza Seasona
1⫹FLUc
%
(⫾95% CI Half-width)

Overall
Child’s race/ethnicity
Hispanic
White, non-Hispanic
Black, non-Hispanic
Asian, non-Hispanic
American Indian/Alaska Native and other, non-Hispanic
First born
No
Yes
Gender
Male
Female
Poverty statusg
Above, more than $75 000/y
Above, $75 000/y or less
Below
Unknown
Child’s age at start of the inﬂuenza season
6–11 mo
12–16 mo
17–20 mo
Mother’s education level
⬍12 y
12 y
⬎12 y, non–college graduate
College graduate
Mother’s marital status
Widowed/divorced/separated
Never married
Married
Mother’s age
ⱕ19 y
20–29 y
ⱖ30 y
Shot card used
Yes
No
Census region
Northeast
Midwest
South
West
MSA
MSA, central city
MSA, noncentral city
Non-MSA
No. of children ⬍18 y old in household
1
2–3
ⱖ4
Provider facility type
All public
All hospitals
All private
Other, mixed, unknown
Moved from a different stateh
Moved
Did not move
4:3:1:3:3
UTD
Not UTD

Fully Vaccinatedd
P

7.4 (⫾0.7)

%
(⫾95% CI Half-width)

1⫹FLUe
P

4.4 (⫾0.5)
⬍.01

5.8 (⫾1.3)
8.5 (⫾0.8)
4.8 (⫾1.5)
12.1 (⫾5.0)
3.6 (⫾2.6)
⬍.01

⬍.01

⬍.01

⬍.01

⬍.01

⬍.01

⬍.01

⬍.01
4.0 (⫾1.4)
6.3 (⫾1.9)
10.2 (⫾1.1)
7.2 (⫾2.0)

.06
14.0 (⫾3.7)
17.8 (⫾1.1)

⬍.01
5.3 (⫾0.6)
1.1 (⫾0.5)

⬍.01
11.2 (⫾1.7)
7.9 (⫾1.0)
5.3 (⫾1.8)

10.3 (⫾2.4)
18.6 (⫾3.7)
20.3 (⫾1.5)
13.9 (⫾2.5)

2.7 (1.2)
4.6 (0.5)

⬍.01
7.2 (⫾1.0)
10.3 (⫾1.4)
6.3 (⫾1.4)

20.8 (⫾2.1)
17.2 (⫾1.4)
12.7 (⫾2.9)

1.8 (⫾1.0)
3.1 (⫾1.4)
5.5 (⫾0.7)
3.5 (⫾1.2)

4.9 (⫾1.7)
7.6 (⫾0.7)

⬍.01

⬍.01

⬍.01

.01
10.0 (⫾1.9)
9.8 (⫾1.6)
7.0 (⫾1.1)
8.3 (⫾1.9)

15.9 (⫾1.6)
20.6 (⫾1.9)
13.1 (⫾1.9)

5.7 (⫾1.0)
4.4 (⫾0.7)
1.9 (⫾1.1)

3.2 (⫾1.2)
6.9 (⫾2.1)
8.8 (⫾0.9)
6.2 (⫾1.6)

.06

⬍.01

⬍.01

.41
8.9 (⫾1.4)
8.2 (⫾0.9)

20.8 (⫾2.7)
17.6 (⫾2.1)
16.4 (⫾1.8)
16.8 (⫾2.5)

4.3 (⫾0.8)
5.1 (⫾0.9)
2.8 (⫾0.8)

9.5 (⫾1.3)
7.3 (⫾0.9)
3.8 (⫾1.4)

.77

⬍.01

.01

⬍.01
3.6 (⫾2.9)
6.1 (⫾1.1)
11.0 (⫾1.2)

17.7 (⫾1.8)
17.4 (⫾1.4)

5.0 (⫾1.2)
5.4 (⫾1.0)
3.3 (⫾0.6)
4.9 (⫾1.4)

7.4 (⫾1.0)
8.1 (⫾1.1)
5.5 (⫾1.3)

⬍.01

.99

⬍.01

⬍.01
3.7 (⫾1.8)
4.5 (⫾1.1)
10.3 (⫾1.0)

14.4 (⫾7.4)
14.4 (⫾1.6)
20.7 (⫾1.5)

4.4 (⫾0.7)
4.4 (⫾0.7)

7.8 (⫾1.5)
9.2 (⫾1.4)
6.1 (⫾0.9)
7.4 (⫾1.6)

⬍.01

⬍.01

.69

⬍.01
3.9 (⫾1.6)
7.0 (⫾1.4)
7.8 (⫾1.7)
14.7 (⫾1.6)

11.8 (⫾3.2)
13.5 (⫾2.2)
19.6 (⫾1.4)

1.5 (⫾1.4)
3.5 (⫾0.8)
5.4 (⫾0.7)

7.2 (⫾0.9)
7.5 (⫾0.9)

⬍.01

⬍.01

⬍.01

.29
9.5 (⫾1.8)
8.3 (⫾1.1)
7.7 (⫾1.4)

11.6 (⫾2.4)
16.1 (⫾2.1)
15.7 (⫾2.2)
26.1 (⫾1.9)

2.1 (⫾1.2)
2.7 (⫾0.9)
5.3 (⫾0.7)

6.6 (⫾4.6)
6.3 (⫾1.0)
8.4 (⫾0.9)

⬍.01

⬍.01

⬍.01

⬍.01
15.9 (⫾2.1)
8.2 (⫾1.1)
4.3 (⫾1.4)
8.0 (⫾2.7)

20.5 (⫾2.4)
17.8 (⫾1.6)
14.1 (⫾1.8)

1.9 (⫾0.8)
3.3 (⫾1.0)
4.6 (⫾1.2)
7.9 (⫾1.1)

4.5 (⫾1.6)
6.3 (⫾1.5)
8.1 (⫾0.8)

⬍.01

.10

⬍.01
4.9 (⫾1.4)
5.7 (⫾1.2)
7.7 (⫾1.5)
11.4 (⫾1.2)

.70
8.6 (⫾1.1)
8.3 (⫾1.1)

28.6 (⫾2.7)
17.0 (⫾1.5)
12.6 (⫾2.2)
15.5 (⫾3.4)

4.8 (⫾1.1)
4.7 (⫾0.8)
3.6 (⫾0.9)

⬍.01
7.3 (⫾0.9)
10.4 (⫾1.4)

.72

⬍.01

⬍.01
8.1 (⫾1.3)
7.9 (⫾1.0)
5.6 (⫾1.1)

⬍.01

⬍.01

17.7 (⫾1.6)
17.3 (⫾1.5)

9.8 (⫾1.7)
3.8 (⫾0.6)
2.6 (⫾1.2)
3.6 (⫾1.4)

.04
5.8 (⫾2.6)
8.7 (⫾0.8)

⬍.01
19.7 (⫾1.3)
8.9 (⫾1.7)

P

5.0 (⫾1.2)
11.1 (⫾1.1)
4.4 (⫾1.9)
11.7 (⫾5.6)
6.6 (⫾3.9)

16.1 (⫾1.4)
20.0 (⫾1.8)
.98

⬍.01

%
(⫾95% CI Half-width)
8.4 (⫾0.8)

13.4 (⫾2.1)
20.6 (⫾1.5)
11.3 (⫾3.0)
25.9 (⫾6.6)
20.9 (⫾8.4)

4.4 (⫾0.7)
4.4 (⫾0.8)

14.1 (⫾2.0)
7.1 (⫾0.9)
4.6 (⫾1.4)
6.0 (⫾1.8)

P

⬍.01

⬍.01

.96

Fully Vaccinatedf

17.5 (⫾1.1)

3.5 (⫾0.6)
5.8 (⫾0.9)

7.4 (⫾0.9)
7.4 (⫾1.0)

%
(⫾95% CI Half-width)

⬍.01
2.8 (⫾1.0)
5.4 (⫾0.6)
2.5 (⫾1.1)
8.8 (⫾4.7)
2.1 (⫾2.2)

6.3 (⫾0.8)
9.1 (⫾1.1)

8.7 (⫾0.8)
2.7 (⫾0.8)

2003–2004 Inﬂuenza Seasonb

⬍.01
9.8 (⫾0.9)
3.2 (⫾1.1)

a Inﬂuenza vaccination coverage measures for the 2002–2003 inﬂuenza season are based on data from the 2003 NIS and represent a subset of children included in the NIS. Only those who were
between the ages of 6 and 23 months for the entire period of September 1, 2002, to December 31, 2002, are included in the inﬂuenza vaccination coverage measures (n ⫽ 13 831 关unweighted兴).
b Inﬂuenza vaccination coverage measures for the 2003–2004 inﬂuenza season are based on data from the 2004 NIS and represent a subset of children included in the NIS. Only those who were
between the ages of 6 and 23 months for the entire period of September 1, 2003, to December 31, 2003, are included in the inﬂuenza vaccination coverage measures (n ⫽ 13 881 关unweighted兴).
c Receipt of ⱖ1 inﬂuenza vaccination between September 1, 2002, and December 31, 2002.
d Children were considered fully vaccinated if they had (1) received no doses of inﬂuenza vaccine before September 1, 2002, but then received 2 doses between September 1, 2002, and either the
date of interview or January 31, 2003, or (2) received at least 1 dose of inﬂuenza vaccine before September 1, 2002, and then received at least 1 between September 1, 2002, and December 31, 2002.
e Receipt of ⱖ1 inﬂuenza vaccination between September 1, 2003, and December 31, 2003.
f Children were considered fully vaccinated if they had (1) received no doses of inﬂuenza vaccine before September 1, 2003, but then received 2 doses between September 1, 2003, and either the
date of interview or January 31, 2004, or (2) received at least 1 dose of inﬂuenza vaccine before September 1, 2003, and then received at least 1 between September 1, 2003, and December 31, 2003.
g Deﬁned using US Census Bureau poverty thresholds.
h Unknown responses were excluded (n ⫽ 39 for 2002–2003 and n ⫽ 25 for 2003–2004).

TABLE 3 Multivariable Logistic-Regression Analyses of Inﬂuenza Vaccination Coverage Levels Among Children Aged 6 to 23 Months and
Demographic Characteristics
Demographic Characteristic

Child’s race/ethnicity
Hispanic
White, non-Hispanic
Black, non-Hispanic
Asian, non-Hispanic
American Indian/Alaska Native and other, non-Hispanic
First born
No
Yes
Gender
Male
Female
Poverty statusi
Above, more than $75 000/y
Above, $75 000/y or less
Below
Unknown
Child’s age at start of the inﬂuenza season
6–11 mo
12–16 mo
17–20 mo
Mother’s education level
⬍12 y
12 y
⬎12 y, non–college graduate
College graduate
Mother’s marital status
Widowed/divorced/separated
Never married
Married
Mother’s age
ⱕ19 y
20–29 y
ⱖ30 y
Shot card used
Yes
No
Census region
Northeast
Midwest
South
West
MSA
MSA, central city
MSA, noncentral city
Non-MSA
No. of children ⬍18 y old in household
1
2–3
ⱖ4
Provider facility type
All public
All hospitals
All private
Other, mixed, unknown
Moved from a different state
Moved
Did not move

2002–2003 Inﬂuenza Seasona

2003–2004 Inﬂuenza Seasonb

1⫹FLU,
Adjusted OR
(95% CI)c

Fully Vaccinated,
Adjusted OR
(95% CI)d

1⫹FLU,
Adjusted OR
(95% CI)e

Fully Vaccinated,
Adjusted OR
(95% CI)f

1.4 (0.9–2.2)
1.5 (1.0–2.2)g
Referent
2.1 (1.1–3.8)g
0.9 (0.4–2.1)

1.2 (0.7–2.2)
1.5 (1.0–2.5)
Referent
2.2 (1.1–4.7)g
1.0 (0.3–3.2)

1.3 (0.9–1.9)
1.7 (1.2–2.4)h
Referent
2.0 (1.2–3.3)h
2.8 (1.5–5.1)h

1.1 (0.6–2.0)
1.8 (1.0–3.0)g
Referent
1.6 (0.7–3.5)
1.8 (0.8–4.1)

0.8 (0.6–1.1)
Referent

0.6 (0.4–0.9)g
1.0 Referent

0.9 (0.7–1.2)
Referent

0.9 (0.6–1.3)
Referent

1.0 (0.8–1.2)
Referent

1.0 (0.8–1.3)
Referent

1.1 (0.9–1.2)
Referent

1.1 (0.9–1.3)
Referent

2.1 (1.3–3.4)h
1.2 (0.8–1.9)
Referent
1.1 (0.7–1.8)

1.6 (0.8–3.1)
0.8 (0.5–1.5)
Referent
.0 (0.5–2.0)

1.4 (1.1–1.9)g
1.0 (0.8–1.3)
Referent
1.0 (0.7–1.5)

1.4 (0.9–2.2)
1.1 (0.7–1.6)
Referent
1.3 (0.8–2.2)

1.5 (1.1–2.0)h
1.4 (1.1–1.8)h
Referent

1.4 (1.0–2.0)g
1.3 (1.0–1.8)
Referent

1.7 (1.3–2.1)h
1.4 (1.1–1.7)h
Referent

1.3 (1.0–1.7)
1.1 (0.9–1.4)
Referent

Referent
1.0 (0.7–1.5)
1.3 (0.8–2.0)
1.4 (0.9–2.1)

Referent
1.4 (0.8–2.5)
1.7 (0.9–3.2)
2.1 (1.2–3.7)g

Referent
1.3 (0.9–1.7)
1.1 (0.8–1.5)
1.5 (1.1–2.1)h

Referent
1.4 (0.8–2.3)
1.2 (0.7–2.1)
1.7 (1.0–3.0)g

Referent
1.5 (1.0–2.4)
1.3 (0.8–1.9)

Referent
1.5 (0.8–2.9)
1.7 (0.9–3.2)

Referent
1.4 (0.9–2.0)
1.4 (1.0–2.0)

Referent
1.5 (0.9–2.7)
2.0 (1.1–3.5)g

Referent
0.8 (0.4–1.8)
0.8 (0.4–1.9)

Referent
1.7 (0.6–4.8)
1.8 (0.6–5.2)

Referent
0.8 (0.5–1.5)
1.0 (0.5–1.8)

Referent
1.3 (0.6–3.0)
1.6 (0.7–3.9)

1.0 (0.8–1.2)
Referent

1.0 (0.8–1.3)
Referent

1.0 (0.9–1.2)
Referent

1.1 (0.9–1.4)
Referent

1.1 (0.8–1.4)
1.5 (1.1–1.9)h
Referent
1.1 (0.9–1.5)

1.2 (0.8–1.7)
1.5 (1.1–2.0)h
Referent
1.4 (1.0–1.9)

1.0 (0.8–1.3)
1.0 (0.8–1.2)
Referent
0.9 (0.7–1.2)

1.1 (0.8–1.4)
1.2 (1.0–1.6)
Referent
1.1 (0.8–1.5)

1.3 (0.9–1.7)
1.1 (0.8–1.5)
Referent

1.5 (1.0–2.1)g
1.3 (0.9–1.9)
Referent

1.3 (1.0–1.6)g
1.4 (1.2–1.8)h
Referent

1.2 (0.9–1.7)
1.4 (1.0–1.9)g
Referent

1.7 (1.0–2.8)g
1.6 (1.0–2.4)g
Referent

1.6 (0.8–3.2)
1.8 (0.9–3.3)
Referent

1.3 (0.9–2.0)
1.2 (0.9–1.6)
Referent

1.5 (0.9–2.6)
1.2 (0.8–1.8)
Referent

Referent
1.9 (1.1–3.2)g
2.1 (1.4–3.2)h
1.8 (1.1–2.9)g

Referent
1.4 (0.7–2.8)
1.9 (1.0–3.4)g
1.6 (0.9–3.1)

Referent
1.7 (1.2–2.5)h
1.5 (1.1–2.1)h
1.2 (0.8–1.6)

Referent
1.3 (0.8–2.2)
1.6 (1.0–2.4)g
1.4 (0.8–2.3)

Referent
1.5 (1.0–2.3)g

Referent
1.7 (1.1–2.8)g

Referent
1.3 (0.9–1.8)

Referent
1.5 (0.9–2.5)

a Inﬂuenza vaccination coverage measures for the 2002–2003 inﬂuenza season are based on data from the 2003 NIS and represent a subset of children included in the NIS. Only those who were
between the ages of 6 and 23 months for the entire period of September 1, 2002, to December 31, 2002, are included in the inﬂuenza vaccination coverage measures (n ⫽ 13 831 关unweighted兴).
b Inﬂuenza vaccination coverage measures for the 2003–2004 inﬂuenza season are based on data from the 2004 NIS and represent a subset of children included in the NIS. Only those who were
between the ages of 6 and 23 months for the entire period of September 1, 2003, to December 31, 2003, are included in the inﬂuenza vaccination coverage measures (n ⫽ 13 881 关unweighted兴).
c Receipt of ⱖ1 inﬂuenza vaccination between September 1, 2002, and December 31, 2002.
d Children were considered fully vaccinated if they had (1) received no doses of inﬂuenza vaccine before September 1, 2002, but then received 2 doses between September 1, 2002, and either the
date of interview or January 31, 2003, or (2) received at least 1 dose of inﬂuenza vaccine before September 1, 2002, and then received at least 1 between September 1, 2002, and December 31, 2002.
e Receipt of ⱖ1 inﬂuenza vaccination between September 1, 2003, and December 31, 2003.
f Children were considered fully vaccinated if they had (1) received no doses of inﬂuenza vaccine before September 1, 2003, but then received 2 doses between September 1, 2003, and either the
date of interview or January 31, 2004, or (2) received at least 1 dose of inﬂuenza vaccine before September 1, 2003, and then received at least 1 between September 1, 2003, and December 31, 2003.
g P ⬍ .05 for comparison with the referent group.
h P ⬍ .01 for comparison with the referent group.
i Deﬁned using US Census Bureau poverty thresholds.
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for all children aged 6 to 23 months, influenza coverage
was low and there was significant variability according
to demographic and immunization-provider characteristics. In addition, of the 7.4% and 17.5% of children
receiving ⱖ1 dose of influenza vaccine in the 2 influenza
seasons, 40% and 52%, respectively, did not receive
their second dose to become fully vaccinated and thus
were suboptimally protected against influenza.
The pattern of differences we found in influenza vaccination coverage according to demographic characteristics is similar to differences in coverage reported in
studies of other childhood immunizations.10–13 Previous
studies have found lower 4:3:1:3 (defined as receipt of
ⱖ4 doses of diphtheria and tetanus toxoids and pertussis
vaccine, ⱖ3 doses of poliovirus vaccine, ⱖ1 dose of any
measles-containing vaccine, and ⱖ3 doses of H influenzae
type b vaccine) and 4:3:1:3:3 coverage among children
living below the poverty level.10,12 Lower maternal education level and a larger number of children in the
household has also been found to be associated with low
vaccination coverage with childhood vaccines.13 We
found that children vaccinated at only public clinics had
lower influenza vaccination coverage than those vaccinated elsewhere or at a mixture of facility types; this has
been found for other childhood vaccinations as well.12
Although our study demonstrated low influenza vaccination coverage among children of all races/ethnicities,
we found that black non-Hispanic children had lower
vaccination coverage than both white non-Hispanic and
Asian non-Hispanic children. Although racial and ethnic
disparities in routine vaccination coverage among children have been reduced substantially, a recent study by
Chu et al14 reported that a disparity in 4:3:1:3:3 UTD
immunization coverage between white non-Hispanic
and black non-Hispanic children has been increasing in
recent years. Other studies of influenza vaccination have
consistently found large disparities between non-Hispanic white and non-Hispanic black elderly adults.5,15–22
The racial/ethnic disparity in childhood influenza vaccination coverage found in this study will require careful
monitoring and targeted interventions that are effective
in reversing the trend, if it continues over time, to mirror
the adult influenza vaccination disparity.
Influenza vaccination of all children aged 6 to 23
months represents a unique challenge to immunization
providers. It is different from other routinely recommended childhood vaccinations because influenza vaccination must be administered annually and during a
fairly limited time period. Also complicating influenza
vaccination of young children is the recommendation
that children aged ⱕ8 years receiving the vaccine for the
first time should receive 2 doses, scheduled at least 4
weeks apart.23 Receipt of 2 doses for previously unvaccinated children is paramount, because receipt of only 1
dose may provide little to no protection; in studies of
pediatric influenza vaccine effectiveness, receipt of only

1 dose of vaccine among previously unvaccinated children ⬍2 years of age was found to not provide protection compared with 2 doses.24–26 Thus, efforts directed at
maximizing the number of children who are fully vaccinated each season are particularly important to optimize protection from influenza.
The feasibility of implementation of the influenza
vaccination recommendation to all children aged 6 to 23
months was studied recently.27–31 Implementation of the
universal influenza vaccination has been estimated to
substantially increase the number of provider visits required to become fully vaccinated for influenza, with as
many as 74% of 6- to 23-month-olds requiring at least 1
additional visit for vaccination if only well-child care
visits were used for vaccination.29 Vaccination clinics or
sessions at which many children can be vaccinated for
influenza have been suggested as a way to manage the
large increase in visits.27,28,30 Providers have also expressed concern about the inability to identify children
who are eligible for vaccination; tracking of eligible
children and reminder/recall systems may facilitate implementation of this universal recommendation by addressing this barrier.27 Although new vaccine recommendations often raise concerns about their impact on
the delivery of other vaccines, a recent study examining
influenza vaccination of 6- to 23-month-olds within a
group of inner-city clinics did not reveal an associated
delay in receipt of the other recommended vaccines.31
During the 2002–2003 influenza season, expanded
pediatric influenza vaccination had not yet been included in the Vaccines for Children (VFC) program and
may not have been covered by the majority of private
health plans. Both the lack of VFC program and insurance coverage for this vaccine and the lack of a full
recommendation likely contributed to the low coverage
observed in 2002–2003. Beginning in the 2003–2004
influenza season, however, the ACIP voted to include
annual influenza vaccination for 6- to 23-month-old
children and the household contacts of children ⬍2
years of age in the VFC program. This expansion of VFC
program coverage for influenza vaccine enables providers to administer public-purchased influenza vaccine to
the most vulnerable groups of children (ie, Medicaid
enrollees, the uninsured, Native American/Alaska Native children, and children whose health insurance does
not cover the cost of vaccination when they are served in
federally qualified or rural health centers). This program
reduces out-of-pocket costs for the parents of these children, which is an evidence-based strategy for increasing
immunization coverage levels.32
Influenza vaccine supply was unlikely to have contributed to the low vaccination coverage in the 2002–
2003 influenza season, because there were no influenza
vaccine shortages or delays during that season. Although
there was not a vaccine-supply shortage during the
2003–2004 season, the season was unusual in several
PEDIATRICS Volume 118, Number 3, September 2006
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respects. Influenza activity began earlier than most seasons, with peak activity occurring in December, and it
was a moderately severe season in terms of mortality.33
There were 152 influenza-associated deaths of children
in the United States reported to the Centers for Disease
Control and Prevention.33 The substantial publicity surrounding these influenza-related deaths of children and
the early onset of the influenza season led to a large
increase in demand for influenza vaccine, exceeding
demand in previous years.
During the subsequent 2004 –2005 season, a dramatic
influenza vaccine-supply shortage prompted the addition of questions to the Behavioral Risk Factor Surveillance System (BRFSS) to rapidly assess influenza vaccination coverage. National reported vaccination coverage
data from September 1, 2004, to January 31, 2005,
collected in February 2005 indicated that coverage with
at least 1 dose of influenza vaccine for children aged 6 to
23 months was 48.4%.34 Although a comparison of these
results with findings from our study must be interpreted
with caution because of the different methods used by
the 2 surveys, the BRFSS assessment suggests that
progress was made in implementation of influenza vaccination among 6- to 23-month-old children between
2002 and 2004. An important methodologic difference
between the surveys is the reliance of BRFSS on parental
report of pediatric influenza vaccination, whereas the
NIS uses only provider-reported data; the validity of
parental report of pediatric influenza vaccination is not
known at this time. In addition, the BRFSS survey did
not assess the proportion of children vaccinated with 1
vs 2 doses, which is critical for understanding the extent
of protection offered by influenza vaccination of young
children.
Despite the significant vaccine shortage in 2004, the
vaccine coverage level found in BRFSS suggests that
there was success in targeting vaccine to this group,
which was one of the ACIP’s recommended priority
groups for vaccination during the shortage.35 It is also
noteworthy that among BRFSS respondents with an
unvaccinated child aged 6 to 23 months, most (62.9%)
thought that the vaccine was not needed for their children.36 These results suggest that although the uptake
has been higher in the first year of recommendation
compared with the first 2 years of the encouragement,
there remains much work to raise awareness among
parents of children in this age group about the recommendation for annual influenza vaccination.
The findings in this report are subject to at least 4
limitations. First, NIS is a telephone survey, and although statistical adjustments compensate for nontelephone households, some bias might remain. Second, the
NIS relies on provider-verified vaccination histories;
therefore, incomplete records and reporting could result
in underestimates of coverage. The third limitation has
to do with 2 decisions we made in our analysis that may
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have influenced, in opposite directions, the vaccination
coverage estimates. The first decision was that we chose
to limit our analysis to only those vaccinations given
from September 1 to December 31 for the ⱖ1-influenzavaccination measure and September 1 to January 31 (or
date of interview if interview occurred before January
31) for the fully vaccinated measure, although some
vaccinations may have occurred after these months and
were not counted. This approach served to lower both
measures of influenza vaccination coverage reported
here, particularly the estimate of fully vaccinated children, because difficulty in scheduling and returning for
the second dose of influenza vaccine may result in the
second dose being received later in the influenza season.
The second decision was that we restricted our measurement of vaccination coverage to those who were aged 6
to 23 months during the entire influenza vaccination
time period of September 1 to December 31. Children in
this age group were eligible for vaccination under the
ACIP encouragement for the entire period of assessment,
with their caregivers and providers having the same
amount of time to ensure vaccination. It is likely that
this sample of children has higher vaccination coverage
than children who were aged 6 to 23 months during
only a portion of the 4-month vaccination interval,
thereby inflating our coverage estimate. A fourth limitation was that we did not take into account the minimum 4-week interval between a first and second dose of
influenza vaccine when defining our measures of immunization coverage.
CONCLUSIONS
We have found that influenza vaccination coverage
among children aged 6 to 23 months was low during the
first 2 years of the encouragement, with many children
receiving only 1 of 2 needed doses. Continued monitoring of influenza vaccine uptake will be important to
track progress and identify risk factors for undervaccination. Additional studies are needed to determine the
reasons for variation in coverage reported here as well as
the failure to achieve full vaccination among such a large
percentage of children.
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